ACCP Annual Meeting
We are excited to be presenting at this conference!
Decentralizing Study Design & Novel Strategies: Can Real World Data Supplement Randomized Controlled Trials and Vice Versa? Lessons Learned from COVID-19
Jaap Mandema, PhD|
Chief Innovation Officer, Certara
This Seminar is useful for PharmDs, PhDs and MDs interested in current developments including dose determination from preclinical pharmacokinetic/ pharmacodynamic (PK/PD) studies, repurposing of drugs for new formulations or indications using 505(b)(2), novel & decentralized clinical study designs and novel partial opioid receptor agonists with improved safety profile.
Are DDI Magnitudes Different in Older Adults than Younger Adults?
Alice Ke, PhD|
Senior Director of PBPK Consultancy, Certara
This Symposium will be useful for PhDs, MDs, PharmDs and RNs who are interested in geriatric clinical pharmacology.